Trending...
- Green Revolution CBD Spotlights Its Water-Soluble Focus Tincture With CBD, CBG and Lion's Mane
- Tacoma: Applicants Sought for the Bicycle Pedestrian Technical Advisory Group
- Tacoma: Closures Projected to Allow for Arterial Work
SEATTLE--(BUSINESS WIRE)--Sound Life Sciences, a pioneer in contactless respiratory monitoring with its proprietary sonar software for consumer smart devices, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The privately-held telehealth startup's smartphone or smartspeaker app produces inaudible ultrasonic sonar pulses to detect reflections caused by nearby patient respiration.
The prescription-only application can be used in home or clinical settings to measure breathing. Testing as part of the FDA submission involved patients with conditions such as chronic respiratory pulmonary disease (COPD), asthma, congestive heart failure and anxiety.
"We're using this regulatory momentum to accelerate commercialization of our technology and begin to identify select partners to bring our software to market," said Jacob Sunshine, MD, Chief Medical Officer and Co-Founder of Sound Life Sciences. "This is just the beginning. With this foundational clearance we have established a regulatory foothold, from which we can build out additional use cases including for respiratory chronic disease management such as asthma and COPD, opioid safety monitoring, infant monitoring, incipient respiratory infection detection and identifying when an unwitnessed cardiac arrest occurs. There are many clinical conditions you can point this at and we are laser focused on conditions where detecting aberrant breathing can lead to an evidence-based intervention and clearly provide value."
More on Washingtoner
"It's critical that our contactless technology utilizes devices like a smartphone or even smartspeaker platforms which are familiar to most patients, and offers health care providers in a telehealth setting critical information to make the most informed clinical decisions for their patients," said Shyam Gollakota, PhD, CEO and Co-Founder of Sound Life Sciences. "Because Sound Life Sciences leverages ubiquitous devices, our technology can rapidly and unobtrusively scale to serve large and diverse populations in both urban and rural communities, especially as it does not require any additional hardware."
Sound Life Sciences has received more than $2.5MM in funding from the National Institutes of Health and the Biomedical Advanced Research and Development Authority (BARDA). Research from the company's founders has been published in more than a dozen peer-reviewed journals and featured in top-tier media outlets including New York Times, Washington Post, STAT, ABC News and Scientific American.
Follow the latest from Sound Life Sciences on Twitter and LinkedIn.
More on Washingtoner
About Sound Life Sciences: The University of Washington spinout, founded in 2018, is a computational health company that builds clinically validated software for mobile phones and smart speakers to advance human health.
Contacts
Eric Schudiske eric@s2spr.com
The prescription-only application can be used in home or clinical settings to measure breathing. Testing as part of the FDA submission involved patients with conditions such as chronic respiratory pulmonary disease (COPD), asthma, congestive heart failure and anxiety.
"We're using this regulatory momentum to accelerate commercialization of our technology and begin to identify select partners to bring our software to market," said Jacob Sunshine, MD, Chief Medical Officer and Co-Founder of Sound Life Sciences. "This is just the beginning. With this foundational clearance we have established a regulatory foothold, from which we can build out additional use cases including for respiratory chronic disease management such as asthma and COPD, opioid safety monitoring, infant monitoring, incipient respiratory infection detection and identifying when an unwitnessed cardiac arrest occurs. There are many clinical conditions you can point this at and we are laser focused on conditions where detecting aberrant breathing can lead to an evidence-based intervention and clearly provide value."
More on Washingtoner
- TOKSTAR Welcomes NBA 2K Star Young Wayne
- Matt Zavala of Zavala Law, PC Elected to Ventura County Bar Association Board of Directors
- Montana Artist Ryan Jolley Receives Goodman Award at Mountain Oyster Club Art Show
- Make Your Move to Luxury Living at Heritage at Hopewell with Rates Starting at Just 3.750% (5.803% APR)
- Scott Glickson Joins STS Capital Partners as Managing Director
"It's critical that our contactless technology utilizes devices like a smartphone or even smartspeaker platforms which are familiar to most patients, and offers health care providers in a telehealth setting critical information to make the most informed clinical decisions for their patients," said Shyam Gollakota, PhD, CEO and Co-Founder of Sound Life Sciences. "Because Sound Life Sciences leverages ubiquitous devices, our technology can rapidly and unobtrusively scale to serve large and diverse populations in both urban and rural communities, especially as it does not require any additional hardware."
Sound Life Sciences has received more than $2.5MM in funding from the National Institutes of Health and the Biomedical Advanced Research and Development Authority (BARDA). Research from the company's founders has been published in more than a dozen peer-reviewed journals and featured in top-tier media outlets including New York Times, Washington Post, STAT, ABC News and Scientific American.
Follow the latest from Sound Life Sciences on Twitter and LinkedIn.
More on Washingtoner
- Spokane: City Closures Planned for the Thanksgiving Holiday
- BREAKTHROUGH TROP2 Research Reveals New REQORSA® Opportunities as Roche Collaboration Strengthens Precision Lung Cancer Strategy
- Tacoma: Planning Commission to Hold Public Hearing on December 16 Regarding Proposed Tree and Landscape Code Update
- Enjoy the 2026 holidays with Spokane Parks & Recreation
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Dallas–Fort Worth
About Sound Life Sciences: The University of Washington spinout, founded in 2018, is a computational health company that builds clinically validated software for mobile phones and smart speakers to advance human health.
Contacts
Eric Schudiske eric@s2spr.com
0 Comments
Latest on Washingtoner
- Record Q3 Revenue and Gross Profit Delivered: Revenue Surges 40%, Gross Margin Soars to 36% & Adjusted EBITDA Loss Narrows 64% for Cycurion, Inc $CYCU
- Inaugural 12 Trees of Christmas gala raises $525,000 for DMG research and family support
- BitTitan Expands MigrationWiz with SharePoint Sites Migration and Simplified Collaboration Licensing
- Olympic champion Katie Moon to compete at Pole Vault in Paradise in Key West
- Smith Strong Merges With Gravis Law, Bringing Gravis Law to Virginia
- Turkish Engineer Who Cracked Wall Street's Algorithm Launches Hermes AI Analyzer
- UK Financial Ltd Launches MayaSwap On MAYA CHAIN To Facilitate UKFLMS-For-Gold Swaps, Officially Transforming UKFLMS From Meme Into A Real-World Asset
- The Great Junk Hunt Returns to Puyallup: The Ultimate Holiday Vintage Market is Back!
- Green Revolution CBD Spotlights Its Water-Soluble Focus Tincture With CBD, CBG and Lion's Mane
- Entrepreneur Nouho M Kanneh Talks Family, Faith and a $37 Million Portfolio in New Interview
- Emerald Williams Selected to Super Lawyers Rising Stars 2022-2026
- Coming Up on CNBC: Bilha Wachira Champions Financial Protection During Long-Term Care Awareness Month
- Tacoma: Closures Projected to Allow for Arterial Work
- Tacoma: Applicants Sought for the Bicycle Pedestrian Technical Advisory Group
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
- Stamp Me Launches Web App Ahead of 15th Anniversary
- The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
- Spokane City Council Passes Chronic Nuisance Properties Ordinance